|
|
Volumn 102, Issue 5, 2008, Pages 559-567
|
|
The Editor's Roundtable: Lipid Management Beyond Statins-Reducing Residual Cardiovascular Risk
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BILE ACID SEQUESTRANT;
COLESEVELAM;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
SIMCOR;
SIMVASTATIN;
STATIN;
UNCLASSIFIED DRUG;
ARTICLE;
ATHEROSCLEROSIS;
CARDIOLOGIST;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CIGARETTE SMOKING;
CLINICAL PROTOCOL;
CORONARY ARTERY DISEASE;
COST EFFECTIVENESS ANALYSIS;
DIABETES MELLITUS;
DRUG DOSE INCREASE;
DRUG MEGADOSE;
DYSLIPIDEMIA;
HEART ATRIUM FIBRILLATION;
HEART PROTECTION;
HIGH RISK PATIENT;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
LIFESTYLE MODIFICATION;
METABOLIC DISORDER;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK FACTOR;
RISK REDUCTION;
UNSTABLE ANGINA PECTORIS;
|
|
EID: 50949119251
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2008.06.028 Document Type: Note |
|
Times cited : (9)
|
|
References (5)
|
